CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 1 filers reported holding CUREVAC N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666 | -45.4% | 97,646 | -16.5% | 0.00% | -100.0% |
| Q2 2023 | $1,219 | +74.6% | 116,942 | +16.8% | 0.00% | – |
| Q1 2023 | $698 | -7.5% | 100,160 | -20.0% | 0.00% | – |
| Q4 2022 | $755 | -99.9% | 125,250 | +76.3% | 0.00% | -100.0% |
| Q3 2022 | $561,000 | -81.3% | 71,055 | -67.7% | 0.00% | -50.0% |
| Q2 2022 | $2,994,000 | +86.4% | 220,006 | +168.8% | 0.00% | +100.0% |
| Q1 2022 | $1,606,000 | – | 81,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |